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Abstract 
Royalactin is a glycoprotein essential for the development of long-lived queen honeybees. 
Only larvae fed with royal jelly, containing royalactin, develop into queens. Royalactin plays a 
central role in this process by switching on the epidermal growth factor (EGF) receptor 
signaling pathway which ultimately leads to epigenetic changes and a long-lived queen 
phenotype. Recently it was shown that royalactin by itself also extends lifespan in Drosophila 
melanogaster. Yet, the mechanism by which royalactin promotes longevity remains largely 
unknown. 
We set out to characterize the effects of royalactin on Caenorhabditis elegans lifespan, and 
clarify the possible involvement of EGF signaling in this process. We demonstrate that 
royalactin extends lifespan of this nematode and that both EGF (LIN-3) and its receptor 
(LET-23) are essential to this process. To our knowledge, this is the first report of royalactin-
mediated lifespan extension in a non-insect species. Additionally, we show that royalactin 
enhances locomotion in adult nematodes, implying that royalactin also influences 
healthspan.  
Our results suggest that royalactin is an important lifespan-extending factor in royal jelly and 
acts by promoting EGF signaling in C. elegans. Further work will now be needed to clarify 
which (secondary) signaling pathways are activated by royalactin, and how this ultimately 
translates into an extended health- and lifespan. 
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Disclaimer 
This paper has been accepted to be published in “Experimental Gerontology”. The 
manuscript below has been peer-reviewed, but not yet formatted according to the specific 
journal’s requirements. See also - DOI: 10.1016/j.exger.2014.09.021 
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Abbreviations 
10-HDA   10-hydroxy-2-decenoic acid  
BSA   Bovine Serum Albumin 
dRoyalactin  Deglycosylated royalactin 
dsRNA  Double-stranded RNA  
EGFR   Epidermal growth factor receptor  
hRoyalactin  Heat-treated royalactin 
MRJP1  Major Royal Jelly Protein 1 (royalactin) 
NGM   Nematode growth medium 
pBSA   Thermolysin-treated BSA 
pRoyalactin  Thermolysin-treated royalactin 
RJ   Royal jelly 
RNAi   RNA interference 
RP-HPLC   Reversed-phase high-performance liquid chromatography 
SEM   Standard error of the mean  
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1. Introduction 
Aging, the gradual loss-of-function over time which leads to increased sensitivity to intrinsic 
and external stressors and ultimately death, is the main risk factor for many prominent and 
debilitating diseases in modern society including cancer and dementia. By modulating the 
aging process itself, it might be possible to delay or prevent these diseases (Butler et al. 
2008; Le Couteur et al. 2012). Since the discovery that aging can be altered by modulating 
certain conserved genetic pathways and biochemical processes (Klass 1983; Kenyon 2010; 
López-Otín et al. 2013), scientists have been looking for promising pharmaceutical 
compounds that act on these pathways to confer increased longevity. Such a compound, if 
effective, could bring more health benefits than any dietary manipulation or lifestyle studied 
to date (de Magalhães et al. 2012). 
In search for a compound that might delay aging, one can rely on information from naturally 
long-lived organisms. The western honeybee Apis mellifera displays a strong polyphenism 
with regard to aging: the fertile queen caste is long-lived and typically reaches 1-2 years 
whereas the infertile worker caste only lives 3-6 weeks (Page and Peng 2001). While 
genotypic effects can play a minor role (Lattorff and Moritz 2013), the main factor that 
determines whether a honeybee larva develops into a queen or worker is its nourishment. 
Only those larvae that are continuously fed with royal jelly (RJ) develop into queens (Haydak 
1970). As RJ is the sole food source for queens throughout their lifetime, the question arises 
whether RJ contains the compound(s) responsible for the queen’s long-lived phenotype. 
Whereas RJ is a complex mixture of sugars, proteins, lipids and vitamins (Takenaka 1982), it 
was recently shown that the RJ protein royalactin is essential for queen differentiation 
(Kamakura 2011). Royalactin activates the epidermal growth factor receptor (EGFR) 
signaling pathway in honeybee larvae, which ultimately leads to epigenetic changes and 
queen development. Moreover, Kamakura (2011) showed that royalactin shortens 
development time and increases longevity in the fruit fly Drosophila melanogaster through 
the EGFR signaling pathway, thus demonstrating that the glycoprotein also confers its 
beneficial effects on another insect species. 
RJ has previously been shown to extend lifespan in mice (Inoue 2003) and in the nematode 
Caenorhabditis elegans (Honda et al. 2011). However, the primary factor responsible for this 
lifespan extension remained elusive. Interestingly, one of the main conclusions drawn from 
the study on C. elegans was that RJ proteins are not likely contributors to the lifespan-
extending effect of RJ (Honda et al. 2011), implying that royalactin may not be able to extend 
lifespan in C. elegans. 
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We employed the model organism C. elegans to further study the effect of royalactin on 
longevity. Contrary to the previous report that RJ-mediated longevity is likely not due to RJ 
proteins (Honda et al. 2011), we show that royalactin is able to extend nematode lifespan in 
absence of other RJ constituents. To our knowledge, this is the first report of royalactin-
mediated lifespan extension in a non-insect species. Additionally, we show that royalactin 
increases adult swimming activity in C. elegans and we partly elucidate the mechanism 
through which it exhibits its lifespan-extending effect. 
 
 2. Materials and Methods 
2.1 Royalactin extraction  
RJ, produced by worker honeybees (Apis mellifera, hybrid variety ‘Buckfast’), was purchased 
in a frozen state from the beekeeper Peter Otte (Graide, Belgium). Royalactin was extracted 
from RJ by multiple rounds of ultracentrifugation, as described by Simuth (2001), followed by 
reversed-phase high-performance liquid chromatography (RP-HPLC). The different RP-
HPLC fractions were lyophilized and analyzed by peptide mass fingerprinting using an 
Ultraflex II matrix-assisted laser desorption and ionization time-of-flight mass spectrometer 
(Bruker Daltonics). All fractions uniquely identified as MRJP1 were pooled and stored 
at -20°C before usage in the lifespan experiments (for more details on the methods used see 
appendix A.1 - A.6). We confirmed that these pooled fractions predominantly contain the 
monomeric form of MRJP1, also known as royalactin (appendix A.7).  
2.2 Thermolysin treatment of royalactin 
Part of the purified royalactin was treated with the metalloprotease thermolysin (EC 
3.4.24.27, Sigma, T7902). This reaction was performed in thermolysin digestion buffer (50 
mM Tris, 10 mM CaCl2, 1M NaCl, pH 8.0) at an enzyme-to-substrate ratio of 1:20 during 4 h 
15 min, while shaking at 70°C. Bovine Serum Albumin (BSA, Sigma, A7906) was treated 
likewise in a parallel reaction. After freeze-drying, the efficacy of these treatments was 
verified via mass spectrometric analysis (appendix A.5).  
2.3 Deglycosylation of royalactin 
We removed the N-linked oligosaccharides from royalactin with the glycosidase PNGase F 
(Sigma, P7367). The reaction was performed under non-denaturing conditions in sodium 
phosphate buffer (100 mM, pH 7.0) with 30 U of PNGase F mg-1 protein, during 60 h at 37°C. 
Amicon Ultra-0.5mL 30K centrifugal filters (Millipore) were used to separate the 
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oligosaccharides from deglycosylated royalactin (dRoyalactin). We verified successful 
deglycosylation via SDS-PAGE (appendix A.8). To take into account potential heat 
degradation of royalactin, we subjected royalactin to identical incubation and processing 
steps in the absence of PNGase F. The resulting product is referred to as heat-treated 
royalactin (hRoyalactin).  
2.4 C. elegans maintenance  
The ZB2844 hpa-1(tm3256) and N2 wild-type Bristol strains were obtained from the 
Caenorhabditis Genetics Center (CGC, University of Minnesota, USA). Worms were 
cultivated at 20°C on standard nematode growth medium (NGM) plates with Escherichia coli 
OP50 as a food source. 
2.5 Lifespan experiments 
We tested the effects of royalactin, thermolysin-treated royalactin (pRoyalactin) and 
deglycosylated royalactin (dRoyalactin) on the lifespan of C. elegans. All lifespan 
experiments were performed at 20°C on regular NGM plates or on NGM plates 
supplemented with royalactin and/or BSA (both intact or treated with thermolysin and/or heat; 
see appendix B.1). 
2.5.1 Preparation of NGM agar containing royalactin 
To evaluate the optimal dosage, intact royalactin was added to liquid NGM at three different 
final concentrations: 0.04, 0.4 and 1.6 µg mL-1. pRoyalactin was similarly added to NGM at 
two distinct final concentrations: 0.4 and 1.6 µg mL-1. To exclude nutritional effects, BSA (or 
thermolysin-treated BSA: pBSA) was added to every condition such that the final total 
concentration of protein was 5 µg mL-1 (Table B.1). Two controls were used in which solely 5 
µg BSA mL-1 or no additional protein at all was added to the medium. In the latter case, an 
equal volume of Milli-Q water was added. All plates in the initial experiment were seeded with 
E. coli OP50 as a food source. 
Subsequent lifespan experiments used a concentration of either 1.5 or 1.6 µg royalactin mL-1 
(Tables B.2, B.3 and B.4) and plates were seeded with E. coli HT115(DE3) containing the 
appropriate plasmid construct (see 2.5.4). 
2.5.2 Age synchronization 
Worms were synchronized by isolating eggs from gravid adults through hypochlorite 
treatment (Wood 1988), followed by a sucrose density centrifugation step to separate the 
eggs from cellular debris. Eggs were washed at least four times with S-basal buffer (0.1 M 
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NaCl, 44 mM KH2PO4, 6 mM K2HPO4) and incubated overnight at 20°C while rotating in S-
basal. 
2.5.3 Determination of lifespan 
Synchronous L1 animals were kept on 9.5 cm-diameter NGM plates until they reached the 
young adult stage. Eighteen to twenty-five individuals were then transferred to each assay 
plate (3.5 cm-diameter), corresponding to a total of 72 to 100 individuals per condition. 
During the initial lifespan experiment, animals were transferred to fresh assay plates every 
day until the end of their reproductive period and every 3 days thereafter. In the other 
experiments, in which 5-fluoro-2’-deoxyuridine (Sigma) was used to bypass the high rates of 
internal hatching inherent to the carried out RNAi knockdowns (appendix B.4), animals were 
transferred once every 3-4 days. 
Lifespan was monitored daily starting from the first day of the adult stage (scored as day 0). 
Animals that did not move when gently prodded with a platinum wire were marked as dead. 
Animals that crawled off the plate or died of vulval bursting or internal hatching were 
censored.  
2.5.4 RNAi treatment of worms  
Via regular feeding RNAi (Rual et al. 2004) we knocked down lin-3 (C. elegans EGF-
encoding gene) and let-23 (C. elegans EGFR-encoding gene). E. coli HT115(DE3) producing 
dsRNA for the individual target genes were seeded onto NGM plates containing 1 mM 
isopropyl β-D-1-thiogalactopyranoside and 50 µg mL-1 ampicillin. As a negative control we 
seeded plates with HT115(DE3) carrying the empty pL4440 vector. These bacteria produce 
dsRNA corresponding to the multiple cloning site of the pL4440 vector, which has no known 
target in C. elegans (Rual et al. 2004). As a positive control for the RNAi setup we used 
HT115(DE3) transformed with pL4440(unc-22), which leads to an easily recognizable 
twitching phenotype upon successful RNAi induction in C. elegans (Fire et al. 1998). All RNAi 
constructs were sequenced to verify the identity of the insert (appendix B.3).  
An in-house RNAi construct, referred to as pL4440(let-23), was generated against let-23 
since the only available RNAi clone was incorrectly annotated in the Ahringer RNAi feeding 
library (Qu et al. 2011; appendix B.3). The lin-3 and unc-22 RNAi clones were derived from 
the C. elegans ORF-RNAi library v1.1 (Rual et al. 2004). Worms were raised on RNAi plates 
from the L1 stage onwards throughout development. Lifespan assays were performed as 
described in 2.5.3, providing worms with fresh RNAi assay plates every 3-4 days.  
2.5.5 Statistical analysis 
 
 
7 
 
We used R (R Development Core Team 2013) to construct survival curves (Kaplan-Meier), 
carry out all related statistical analyses and calculate the mean lifespan and standard error of 
the mean (SEM). Kaplan-Meier survival curves were statistically analyzed using a Cox 
Proportional Hazard (to compare multiple conditions) or a log-rank test (to compare a single 
curve to control). The corresponding p-values are referred to as pcox and plog-rank. 
2.6 Locomotion measurements 
We measured swimming activity of C. elegans, using an automated infrared tracking system, 
as described by Meelkop et al. (2012) with a few modifications. In short: adult nematodes 
(day 3.5 of the adult stage) were added to wells of a flat-bottom 96-well plate containing 200 
µL of S-complete medium (Solis and Petrascheck 2011) with a final concentration of 85 µM 
5-fluoro-2’-deoxyuridine to prevent self-reproduction, and 5 µL mL-1 nystatin (Sigma, N1638) 
and 50 mg mL-1 ampicillin to avoid contamination. As a food source we added flash frozen 
E. coli K12 bacteria (Artechno, Isnes, Belgium) until an OD600 of 1.7 was reached. For the 
treated condition, worms were grown on royalactin-containing NGM plates starting from the 
L1 stage (analogous to the lifespan experiments) until transferring them to liquid medium with 
a final concentration of 1.7 µg mL-1 royalactin. Fourteen wells were used for each condition, 
with ca. 30 worms in each well. After a recovery period of three hours, we measured 
locomotion during 24 h with the WormMicrotracker (Designplus) (Simonetta and Golombek 
2007). Activity bins were added up for each well. The results were analyzed using a one-way 
ANOVA followed by a Tukey’s HSD post hoc test.  
 
3. Results  
3.1 Royalactin influences C. elegans lifespan 
3.1.1 No significant effect of BSA on C. elegans lifespan  
To exclude that lifespan extension due to royalactin supplementation would be merely the 
result of a higher amount of protein in the growth medium, we followed the life course of 
worms exposed to BSA. We were unable to detect significant differences in survival between 
worms treated with 5 µg BSA mL-1 and the control (Fig. 1.A; Table 1), indicating that under 
the experimental conditions used, protein supplementation by itself has no significant 
influence on C. elegans lifespan.  
3.1.2 Royalactin extends C. elegans lifespan 
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Royalactin extends lifespan of C. elegans at all three concentrations tested (Fig. 1.A), 
compared to both controls in which either no protein or BSA was added to the medium. With 
increasing concentration of royalactin, the mean lifespan of C. elegans rose with 26.8%, 
29.1% and 33.9%, respectively (Table 1). Though there was no significant difference in 
survival between these three conditions, we observed the strongest lifespan-extending effect 
at a concentration of 1.6 µg royalactin mL-1 (Fig. 1.A). 
3.1.3 pRoyalactin does not extend C. elegans lifespan 
Adding thermolysin-treated royalactin (pRoyalactin) to the medium has no significant 
influence on C. elegans lifespan (Table 1; Fig. 1.B), compared to adding thermolysin-treated 
BSA (pBSA). There is a slight, albeit non-significant, increase in mean lifespan that is clearly 
not as pronounced as with intact royalactin. Thus, the strong lifespan-extending effect of 
royalactin is abolished after thermolysin-treatment. 
3.1.4 Both dRoyalactin and hRoyalactin extend C. elegans lifespan 
To assess whether the N-linked oligosaccharides from royalactin are needed for its lifespan-
extending effect, we removed them from royalactin (see 2.3). Deglycosylated royalactin 
(dRoyalactin) and mildly heat-treated royalactin (hRoyalactin) are both still capable of 
extending C. elegans lifespan (Fig. 1.C; Table 1) to the same extent as intact royalactin. 
Supplementation of NGM with oligosaccharides, which were removed from royalactin, does 
not result in an increase in longevity, compared to the control (Fig. 1.C; Table 1). When 
comparing the oligosaccharide and dRoyalactin condition, we do see a significant difference 
in survival (+19% mean lifespan; plog-rank = 3.26E-4). Taken together, these results indicate 
that the N-linked carbohydrate moieties on royalactin are not needed for its lifespan-
extending effect. 
3.2 Knockdown of the EGF receptor or its ligand abolishes the lifespan-extending 
effect of royalactin 
Based on its known dependence on EGFR signaling in insects (Kamakura 2011), we tested 
the ability of royalactin to influence C. elegans lifespan after knockdown of lin-3 (EGF) or 
let-23 (EGFR). 
As a negative control for the RNAi experiments we used E. coli HT115(DE3) bacteria, 
carrying the empty pL4440 vector, as a food source for wild-type C. elegans (see 2.5.4). As 
expected from the initial lifespan assay (see 3.1), worms treated with 1.5 µg royalactin mL-1 
NGM live significantly longer than those treated with BSA only (Fig. 2.A and Fig. B.1). Mean 
lifespan is increased by 17.5% (Table 2). A similar increase in longevity is seen for worms 
treated with 1.6 µg royalactin mL-1 (Fig. 2.B and Fig B.6; Table 2). Thus, the lifespan-
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extending effect of royalactin is maintained when culturing C. elegans in the presence of 
E. coli HT115(DE3) expressing control dsRNA.  
The genes lin-3 and let-23 encode the EGF ligand and EGFR, respectively. By itself, 
knockdown of lin-3 causes no significant difference in survival (Fig. B.3). However, lin-3 
knockdown clearly abolishes the lifespan-extending effect of royalactin (Fig. 2.A; Table 2). In 
other words: when knocking down lin-3, administering royalactin to C. elegans no longer 
increases mean or median lifespan. Similarly, knockdown of let-23 – which drastically 
decreases survival under standard conditions (-26.8% mean lifespan; Fig 2.B; Fig. B.5) – 
abolishes the lifespan-extending effect of royalactin. During let-23 RNAi, royalactin treatment 
no longer increases mean or median lifespan of C. elegans (Fig. 2.B; Table 2).  
Our data thus demonstrate that the epidermal growth factor (LIN-3) and its receptor (LET-23) 
are essential for royalactin-mediated lifespan extension in C. elegans. 
3.3 Royalactin enhances locomotion in C. elegans  
We compared swimming activity between royalactin-treated and non-treated wild-type worms 
in early to mid-adulthood (from day 3.5 until 4.5 adult) using an automated tracking system. 
As a positive control we used the hpa-1(tm3256) deletion mutant (high performance in 
advanced age) which displays an increased amount of body bends in liquid medium (Iwasa 
et al. 2010). 
Both royalactin-treated and positive control worms show an increase in swimming activity 
compared to the wild-type control (p = 5.41E-9 and 1.50E-5, respectively). Average 
swimming activity increases with ca. 75% upon royalactin treatment (Fig. 3). Additionally, 
royalactin-treated worms display a significant increase in average swimming activity 
compared to the positive control (+20%; p = 5.46E-3). 
 
4. Discussion 
Due to the success of modern medicine, many human populations enjoy a substantially 
increased life expectancy. These ‘added years’ are nevertheless to be balanced with the risk 
of developing many diseases, which increases exponentially with age. If we are to care for 
our elderly, we need to invest in preventing or at least delaying these detrimental age-related 
physiological changes. One way to approach this, is by modulating the fundamental 
mechanisms of aging (Kirkland 2013). This can be achieved by finding compounds that 
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target the aging process across different phyla (Fontana et al. 2010; de Magalhães et al. 
2012; Lucanic et al. 2013).   
4.1 Royalactin confers lifespan-extending properties to royal jelly  
Royalactin, also known as the monomeric form of major royal jelly protein 1 (MRJP1), 
apalbumin-1 and RJP-1, is a glycoprotein unique to A. mellifera and the most abundant 
protein in RJ (Schmitzová et al. 1998; Buttstedt et al. 2014). In 2011, Honda et al. revealed 
that RJ extends lifespan in the nematode C. elegans. We demonstrate that royalactin by 
itself is capable of extending lifespan in C. elegans. To our knowledge, this is the first report 
of royalactin-mediated lifespan extension outside of the insect order. While the highest 
concentration of royalactin provoked the biggest lifespan-extending effect, no clear dose-
dependency can be concluded from this study. Supplementation with the protein BSA 
induces no response, which argues against the possibility that the effects of royalactin are 
simply nutritional. Treating royalactin simultaneously with thermolysin and heat (i.e., 
disrupting the native protein structure) abolishes its lifespan-extending effect, further 
supporting this notion.  
While N-linked glycosylation can play a major role in protein oligomerization and stability 
(Elbein 1991), this modification does not appear to be essential for royalactin to promote 
longevity. Our results show that dRoyalactin extends lifespan in C. elegans, as strongly as 
hRoyalactin, while the isolated carbohydrate moieties have no such effect. This is line with 
previous reports showing that deglycosylated royalactin retains its stimulatory effect on rat 
hepatocytes (Kamakura 2002) and that recombinant royalactin (without carbohydrate 
moieties) still induces queen differentiation in A. mellifera, has stimulatory effects on murine 
macrophages (Majtán et al. 2006) and increases lifespan in D. melanogaster (Kamakura 
2011).  
In literature, part of the lifespan-extending effect of RJ has been attributed to 10-hydroxy-2-
decenoic acid (10-HDA), a fatty acid (Honda et al. 2011). Our results suggest that royalactin, 
rather than 10-HDA, is the main lifespan-extending factor in RJ. Royalactin increases the 
mean lifespan of wild-type C. elegans by 18-34% (depending on the concentration, the 
bacterial food source and agar composition), while the maximum increase in mean lifespan 
with 10-HDA remains limited to 12% (Honda et al. 2011). Since only part of the lifespan-
extending effects of RJ can be attributed to 10-HDA, there are in all likelihood other 
longevity-promoting compounds contained in RJ. While Honda et al. (2011) argued that 
these compounds are unlikely to be intact proteins, we here contrastingly show that RJ-
derived royalactin can extend longevity in C. elegans. However, Honda et al. (2011) do 
suggest that specific proteinaceous fragments (such as peptides and/or proteolysis 
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byproducts) may be in part responsible for the lifespan-extending properties of RJ. This may 
imply that it is not full royalactin, but a specific peptide derived from royalactin that promotes 
longevity.  Our attempts to generate such a fragment using the protease thermolysin were 
unsuccessful thus far. A highly specific combination of proteases and/or incubation times 
may be needed to generate said fragment.   
It is conceivable that 10-HDA plays an auxiliary role in lifespan extension by RJ, for example 
through its histone deacetylase inhibitor activity (Spannhoff et al. 2011; Buttstedt et al. 2014). 
It has been shown that epigenetic alterations (e.g. histone modifications) can play an import 
role in the regulation of the aging process of C. elegans and other organisms (de Magalhães 
et al. 2012; López-Otín et al. 2013). It would be interesting to investigate whether royalactin 
and 10-HDA have additive effects on modulating lifespan, and if these substances induce 
longevity-associated epigenetic changes.  
4.2 Mode of action of royalactin: the epidermal growth factor receptor signaling 
pathway 
Royalactin activates the EGFR signaling pathway in D. melanogaster, A. mellifera and 
primary rat hepatocytes (Kamakura 2002; Kamakura 2011). This pathway has in recent 
years been identified as a crucial regulator of the aging process in C. elegans (Yu and 
Driscoll 2011; Rongo 2011). Moreover, the lifespan increase evoked by royalactin is very 
similar to the one seen in the EGF receptor gain-of-function mutant let-23(sa62) (Liu et al. 
2011).  
These observations led us to investigate the role of EGF signaling in royalactin-mediated 
lifespan extension. Here, we show that knockdown of either lin-3 (EGF) or let-23 (EGFR) 
completely abolishes royalactin-mediated lifespan extension. This is the first experimental 
indication that royalactin acts through the EGFR signaling pathway in C. elegans. 
Despite the efforts of Kamakura (2011) to characterize the interplay between royalactin and 
the EGFR in D. melanogaster, it remained unclear how royalactin interacts with this receptor. 
It is unknown whether royalactin by itself is a ligand of the EGFR, or whether it somehow 
helps endogenous ligand(s) to activate the EGFR. Since we showed that EGF (LIN-3) is 
essential for royalactin-mediated lifespan extension in C. elegans, this points to a mechanism 
wherein royalactin by itself is no ligand of the EGFR, but somehow interacts with LIN-3 to 
promote EGF signaling. One plausible explanation is that royalactin (or a fragment thereof) 
binds to LIN-3, which in turn promotes the binding of the ligand to the extracellular domain of 
the EGFR and thus enhances EGF signaling. Another possibility is that royalactin acts on 
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regulators of EGF signaling (such as HPA-1) and/or promotes the release of LIN-3, which is 
synthesized as a membrane-anchored precursor.  
Although EGF signaling is a known regulator of aging in C. elegans, exactly how royalactin 
treatment results in increased longevity remains to be elucidated. It is unknown which 
(secondary) signaling pathways are activated and how this translates into an extended 
lifespan. One possibility is that royalactin ultimately helps to maintain protein homeostasis 
(proteostasis), known to support healthy aging. Enhanced EGF signaling is directly linked to 
sustaining proteostasis in adult C. elegans (Liu et al. 2011; Rajalingam and Dikic 2011; 
Rongo 2011) while impaired proteostasis is one of the hallmarks of aging (López-Otín et al. 
2013).  
While royalactin is unique to A. mellifera, its target, the EGFR pathway, is highly conserved 
in evolution from C. elegans to humans (Lemmon and Schlessinger 2010). This implies 
royalactin might have the potential to exert its effects in a wide range of organisms, including 
mammals. Previous studies already showed immunostimulatory effects of royalactin (and 
oligomeric MRJP1) on mice macrophages and human monocytes (Kimura et al. 1995; 
Majtán et al. 2006), as well as enhanced proliferation of rat liver cells via increased EGFR 
signaling (Kamakura 2002). However, a note of caution is due: while a small increase in 
EGFR activity could prove beneficial for healthy aging, augmented EGFR signaling is also 
associated with epithelial cancers (Rajalingam and Dikic 2011). Further research will have to 
clarify whether the beneficial effects of royalactin on longevity or other traits might also be 
present in other organisms. 
4.3 Royalactin and healthspan  
Since the link between royalactin and lifespan extension has only recently been established, 
there are still many unanswered questions. Little is known about whether royalactin also 
positively impacts other traits of living organisms and genuinely results in healthy aging, 
rather than simply prolonging an aged state.  
Royalactin increases fecundity in D. melanogaster (Kamakura 2011), so it would be 
interesting to investigate whether royalactin has a similar influence on C. elegans. The EGFR 
- which is stimulated by royalactin - regulates reproduction and fertility in adult worker 
honeybees (Formesyn et al. 2014). This shows that EGF signaling is not only needed during 
larval development, but also plays an important role in regulating fertility during adulthood - at 
least in the honeybee. 
Since royalactin seems to activate the EGFR in C. elegans, it is likely that royalactin not only 
increases lifespan but also healthspan of C. elegans. The activation of LET-23 is associated 
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with maintaining muscle function and integrity, a reduced accumulation of age pigments and 
a higher rate of locomotion during old age (Iwasa et al. 2010; Yu and Driscoll 2011). 
Similarly, we showed that royalactin-treatment positively influences the rate of locomotion 
during early to mid-adulthood (see 3.3), implying that royalactin also extends nematode 
healthspan. Our observations point to a compression of morbidity until near the end of life, 
rather than merely an extended lifespan in poor health.  
4.4 Promising developments and perspectives 
It seems conceivable that in the future, clinical interventions might be developed that could 
delay or prevent age-related changes in humans (de Magalhães et al. 2012; Kirkland 2013). 
Some of these interventions could be based on natural products (like RJ), extracts thereof 
(such as royalactin or 10-HDA) or other compounds that target key regulators of the aging 
process. 
Phase III clinical trials are already underway to assess the effects of RJ on elderly people 
(Niu et al. 2013). Preliminary results show that the daily intake of RJ improves muscle 
strength and physical performance in elderly volunteers, as seen in mice both in vitro and in 
vivo (Niu et al. 2013). Yet, care should be taken since sufficient data are lacking. 
Furthermore, since RJ can contain a number of contaminants, such as antibiotics, that may 
cause possible adverse reactions (Bogdanov 2005), it might not be suited as an efficient 
method of treatment in its current form. In this context, it is paramount to identify the actual 
component(s) of RJ that result in an extended lifespan and healthspan. Our results indicate 
that royalactin is at least one of these compounds. Moreover, we show that the N-linked 
oligosaccharides of royalactin – which are putative human allergens in RJ (Hayashi et al. 
2011) – are not required to promote longevity, which brings it one step closer to being used 
as a nutraceutical. 
Additionally, analysis of the involved molecular mechanisms could identify new drug targets 
for longevity promotion (de Magalhães et al. 2012). As such, we believe a better 
understanding of the interaction of royalactin with genetic pathways and biochemical 
processes conserved in evolution might contribute to the long-term development of 
therapeutic interventions that target the human aging process. Modulating the fundamental 
mechanisms of aging – to delay several age-related diseases as a group, rather than one at 
a time – is a promising approach that is quickly gaining traction (Kirkland 2013). 
 
5. Conclusions 
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Taken together, our results suggest that the glycoprotein royalactin is an important lifespan-
extending factor in royal jelly and acts by promoting EGF signaling. Both EGF and its 
receptor seem to be essential for royalactin to exert its positive effects on longevity, whereas 
the N-linked oligosaccharides of royalactin are not required for its activity. Further work will 
now be needed to clarify which (secondary) signaling pathways are activated by royalactin, 
and how this ultimately translates into an extended health- and lifespan. 
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Fig. 1. Royalactin and deglycosylated royalactin (dRoyalactin), but not BSA nor thermolysin-treated royalactin
(pRoyalactin), prolong lifespan of C. elegans. (A) 5 µg BSA mL-1 has no significant effect on C. elegans lifespan (plog-rank
= 0.668; pcox = 0.675), compared to the condition with no additional protein. All three tested concentrations of royalactin
significantly extend lifespan of C. elegans, compared to both a control in which no protein was added (pcox(0.04 µg) =
4.15E-4; pcox(0.4 µg) = 9.19E-4; pcox(1.6 µg) = 5.75E-5) and a control supplemented with BSA (Table 1).
(B) After thermolysin-treatment, the strong lifespan-extending effect of royalactin is abolished. There is no significant
difference in survival between both pRoyalactin conditions and the pBSA condition (plog-rank(pRoyalactin 0.4 μg) = 0.409;
plog-rank(pRoyalactin 1.6 μg) = 0.101). (C) Royalactin retains it lifespan-extending effect after deglycosylation (plog-rank = 2.02E-5)
and mild heat-treatment (plog-rank = 1.25E-4), whereas the isolated oligosaccharides do not extend lifespan (plog-rank =
0.415). 
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Fig. 2. Knockdown of the EGF homolog lin-3 (A) or its receptor let-23 (B) abolishes the lifespan-extending effect of 
royalactin on C. elegans (pcox = 3.17E-3 and 2.30E-5, respectively).  
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Fig. 3. Royalactin enhances the swimming rate in
wild-type C. elegans during early to mid-adulthood
(p = 5.41E-9). Means were normalized relative to
the wild-type control. As a positive control we used
the hpa-1(tm3256) deletion mutant (high
performance in advanced age). Error bars indicate
SEM, *** p < 0.001. Each group consists of 14
replicates with 30 animals in each replicate. 
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Table 1. Royalactin extends mean and median lifespan of C. elegans, independent of its N-
linked oligosaccharides.  
a For all conditions with intact royalactin, dRoyalactin, hRoyalactin or oligosaccharides supplemented to the 
medium, the condition BSA was used as control. For all conditions with pRoyalactin in the NGM plates, pBSA was 
used as control. N the total amount of tested worms, SEM the standard error of the mean, N.S. not significant, ** 
pcox < 0.01, *** pcox < 0.001.  
  
 
Condition N  
Mean 
lifespan 
(days ± SEM) 
Increase  
versus 
controla 
 
pcox 
Median 
lifespan 
(days) 
A. Intact royalactin    
 Royalactin 0.04 µg 72  16.1 ± 0.84 26.8% *** 6.82E-4 17  
 Royalactin 0.4 µg 76  16.4 ± 0.90 29.1% ** 1.62E-3 17 
 Royalactin 1.6 µg 74  17.0 ± 0.80 33.9% *** 8.87E-5 18 
 BSA 78  12.7 ± 0.68 - - 14 
 No protein added 73  12.4 ± 0.74 -2.4% N.S. 0.675 14 
B. Protease-treated royalactin  
 pBSA 76  13.6 ± 0.65 - - 14  
 pRoyalactin 0.4 µg 73  14.3 ± 0.66 5.1% N.S. 0.494 14 
 pRoyalactin 1.6 µg 75  14.9 ± 0.83 9.6% N.S. 0.063 14  
C. Deglycosylated royalactin  
 dRoyalactin 96  15.3 ± 0.43 20.5% *** 1.84E-5 15  
 hRoyalactin 95  15.0 ± 0.47 18.1% *** 9.17E-5 15  
 Royalactin 97  15.3 ± 0.38 20.5% *** 6.69E-5 15  
 Oligosaccharide 99  12.9 ± 0.41 1.6% N.S. 0.427 13  
 BSA (control) 98  12.7 ± 0.38 - - 13  
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Table 2. Lifespan extension by royalactin requires LIN-3 and LET-23.  
a For ‘pL4440’ we used the condition ‘pL4440 + BSA’ as control, for ‘RNAi lin-3’ we used ‘RNAi lin-3 + BSA’ as 
control and for ‘RNAi let-23’’ we used ‘RNAi let-23 + BSA’ as control. Hence, the ‘increase versus control’ can be 
considered as the increase in lifespan as a result of royalactin supplementation, in the absence or presence of 
gene knockdown of lin-3 (A) or let-23 (B). N the total amount of tested worms, SEM Standard error of the mean, ** 
pcox < 0.01, *** pcox < 0.001, N.S. not significant, p-values are shown in appendix B.6. 
   
Condition N Mean lifespan (days ± SEM) 
Increase 
versus controla 
Median lifespan 
(days) 
A. lin-3 (EGF) knockdown     
 pL4440 + Royalactin 73 19.5 ± 0.50 17.5% ** 19 
 pl4440 + BSA 77 16.6 ± 0.64 - 17 
 RNAi lin-3 + Royalactin 74 15.5 ± 0.43 -1.9% N.S. 15 
 RNAi lin-3 + BSA 74 15.8 ± 0.52 - 16 
      
B. let-23 (EGFR) knockdown     
 pL4440 + Royalactin 85 21.8 ± 0.41 19.1% *** 22 
 pL4440 + BSA 86 18.3 ± 0.53 - 19 
 RNAi let-23 + Royalactin 86 12.3 ± 0.38 -8.2% N.S. 12 
 RNAi let-23 + BSA 80 13.4 ± 0.47 - 13 
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Appendix A.  
Extraction of royalactin and quality-control 
 
Abbreviations 
ACN   Acetonitrile 
DTT   Dithiothreitol 
IAA   Idoacetamide 
TFA   Trifluoroacetic acid 
MALDI-TOF  Matrix-assisted laser desorption and ionization time-of-flight 
MQ   Milli-Q water 
MS   Mass spectrometry 
PMF   Peptide mass fingerprinting 
SDS-PAGE  Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
 
A.1 Ultracentrifugation of RJ 
Royal jelly was separated into three distinct fractions by centrifuging during 5 hours at 
245,000 g and 6°C (Optima LE-80K Ultracentrifuge, SW 65 Ti rotor, Beckman Coulter, 
Nyon, Switzerland). The middle fraction, composed of a yellow viscous fluid, was 
resuspended in two volumes of Milli-Q water (MQ, Milli-Q Advantage A10 water 
purification system, 0.22 μm filter, Millipore, Molsheim, France). After 1 h of stirring at 
20°C, the milky-white suspension was separated by centrifuging for 30 min at 28,880 g and 
4°C (Sorvall RC 6+ centrifuge, F13S-14X50CY rotor, Thermo Scientific, Waltham, USA). 
This resulted in two fractions: on one hand a sediment of protein aggregates, on the other an 
opalescent micro-emulsion (with a slight yellow tint). By centrifuging the micro-emulsion 
(245,000 g, 5h, 6°C) we obtained a clear supernatant and a stiff golden-yellow gel (RJ-gel) on 
the bottom of the centrifuge tube. After removing the supernatant, the RJ-gel was freeze-dried 
using a Speedvac system (Savant SVC100H, Savant Instruments Inc, Farmingdale, USA). 
This process to obtain a RJ-gel – which is rich in royalactin (MRJP1) – corresponds largely to 
the one described by Simuth (2001). 
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A small amount of RJ-gel (20 µg) was dissolved in MQ and subjected to sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) to verify the presence of royalactin. 
The RJ-gel indeed contains a relative large amount of 55-57 kDa protein (data not shown). 
We also found a distinct protein band at ~5 kDa, indicating the presence of apisimin, which 
forms a stable complex with MRJP1 in RJ (Tamura et al. 2009). While the most intense band 
was the one corresponding to royalactin, further purification was needed due to the presence 
of additional (albeit weak) protein bands (presumably caused by a minor amount of MRJP3, 
MRJP5 and to a lesser extend also MRJP4 and MRJP2). 
A.2 Reversed-phase high-performance liquid chromatography (RP-HPLC) of RJ-gel 
Royalactin was further purified by RP-HPLC of the gel sediment (RJ-gel). We first performed 
an ‘analytical run’, using a small amount of RJ-gel, in which the different peaks were 
captured in four separate fractions for subsequent identification through mass spectrometry 
(MS). Three mg of RJ-gel was dissolved in 2% acetonitrile (ACN, Fluka) and 0.1% 
trifluoroacetic acid (TFA, Sigma) and brought onto a C4 Symmetry™ 300 Column (4.6 mm x 
250 mm, 5 µm, 300 Å, Waters, Milford, USA) while running a linear gradient of 2% to 80% 
ACN in 35 minutes. The four different RP-HPLC fractions were freeze-dried and prepared for 
identification through peptide mass fingerprinting (PMF; see A.3-A.5).  
After confirming the presence of royalactin in fraction 3 and 4, we used a Delta-Pack C4 Prep 
Column (25 x 10 mm, 15 µm, 100 Å, Waters) with a linear ACN gradient from 2% to 80% in 
30 min to obtain larger amounts of royalactin (for usage in the lifespan assays) in a similar 
way. The RP-HPLC fractions from this ‘preparative run’ were also subjected to PMF 
analysis. Protein concentrations were determined using a Qubit protein assay kit (Qubit 1.0 
Fluorometer, Invitrogen, Paisley, Scotland). 
A.3 Tryptic digest of RP-HPLC fractions  
RP-HPLC fractions were subjected to hydrolysis by trypsin for subsequent identification 
through MS. For this, a volume of each RP-HPLC fraction containing ca. 190 µg of protein 
was added to LoBind tubes (Eppendorf, Hamburg, Germany). In case the protein 
concentration was too low to detect (i.e., fraction 1 of the analytical run; < 20 µg protein 
mL-1) the total volume was added.  
Samples were freeze-dried and incubated in 50 µL 30% ACN with 6.6 mM dithiothreitol 
(DTT, GE Healthcare Life Sciences, Uppsala, Sweden) for 5 minutes at room temperature. 
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After lyophilising the solution, samples were dissolved in 50 µL 30% ACN with 55 mM 
idoacetamide (IAA, Applichem GmbH, Darmstadt, Germany) and incubated for 7 minutes, in 
the dark, before drying the samples. Next, the samples were dissolved in 150 µL trypsin 
digestion buffer (50 mM NH4HCO3, 50 mM CaCl2) with 1.27 µg sequencing grade modified 
trypsin (Promega, Madison, USA), corresponding to an enzyme to substrate ratio of 1:150. 
Samples were incubated at 37°C during 10 h while vigorously shaking, after which they were 
again freeze-dried. 
A.4 Sample preparation for MALDI-TOF 
Tryptic samples were subsequently concentrated and desalted using C18 ZipTip pipette tips 
(Millipore). Tryptic peptides were eluted in 5 µL of 70% ACN, 0.1% formic acid (Sigma). 
For each sample, 1 µl of tryptic peptides and 1 µl of matrix (α-cyano-4-hydroxycinnamicacid 
dissolved in 60% ACN and 0.5% TFA) were spotted on a ground steel MALDI plate (Bruker 
Daltonics) and allowed to air dry. 
A.5 Identification of proteins through peptide mass fingerprinting (PMF) 
Mass spectrometry was performed on an Ultraflex II matrix-assisted laser desorption and 
ionization time-of-flight (MALDI-TOF) mass spectrometer (Bruker Daltonics) operated in 
reflectron positive ion mode. The instrument was calibrated using peptide calibration 
standard II (Bruker Daltonics). Mass spectra were generated in the software FlexControl 
(version 2.4, Bruker Daltonics) while FlexAnalysis (version 3.0, Bruker Daltonics) was used 
to generate a peak list (with a monoisotopic mass and quality factor for each peak). Proteins 
were identified through PMF using BioTools (version 3.1, Bruker Daltonics) linked to Mascot 
(version 1.0, Matrix Science). A mass tolerance of 200 ppm was used in all searches and we 
allowed one missed cleavage per peptide. Carbamidomethylation (C) and oxidation (M) were 
selected as fixed and variable modifications respectively. We searched the manually 
annotated and reviewed Swiss-Prot database for potential protein identifications. Hits were 
considered significant at a Mascot protein score greater than 70. This method allowed for 
detection of royalactin down to amounts of ca. 150 fmol. 
In fraction 3 and 4 of the analytical RP-HPLC run - and fraction 7, 8 and 9 of the preparative 
RP-HPLC run - we identified royalactin (MRJP1) through PMF MS (see Table A.1). The 
presence of royalactin was confirmed once more (E-value 0.0076; Score 78; 21 matches; 33% 
 
 
26 
 
sequence coverage) through PMF with thermolysin as protease instead of trypsin (cf. 
thermolysin-treatment described in 2.2). 
Table A.1 Identification of royalactin in the RP-HPLC fractions through PMF MS.  
The ‘E-value’ is an estimate for the amount of matches you would find, with a score greater than the 
found value, based on chance alone. The Mascot protein ‘score’ is a logarithmic conversion of the E-
value. The higher the protein score, the lower the probability that the identification is purely chance-
based. ‘Matches’ indicates the amount of observed peptides fragments (corresponding to he identified 
protein), while ‘sequence coverage’ corresponds to the amount of observed amino acid residues 
divided by the total length of the protein. 
Sample Identification E-value Score Matches Sequence coverage (%) 
Analytical fraction 3 MRJP1_APIME 2.7E-5 103 24 60 
Analytical fraction 4 MRJP1_APIME 1.1E-3 87 23 60 
Preparative fraction 7 MRJP1_APIME 1.1E-7 89 13 28 
Preparative fraction 8 MRJP1_APIME 2.9E-12 135 13 26 
Preparative fraction 9 MRJP1_APIME 1.8E-14 157 14 29 
 
A.6 SDS-PAGE of the extracted royalactin 
After pooling royalactin for usage in the lifespan experiments, 
we performed SDS-PAGE to assess the quality of our 
extraction. We mixed 9 µg of the pooled royalactin with 
NuPAGE LDS sample buffer (containing Coomassie G-250 
and Phenol Red as tracking dyes) and NuPAGE reducing agent 
(with a final concentration of 50 mM DTT). After heating the 
sample at 70°C during 10 min, we applied it onto a NuPAGE 
4-12% Bis-Tris Midi polyacrylamide gel (Life Technologies, 
12+2 wells, 1.0 mm thick). We also applied 10 µL of the 
SeeBlue Plus2 Pre-stained Standard (Life Technologies) in a 
neighboring lane, to allow easy visualization of protein 
molecular weight. Next we subjected the gel to 45 min at 200V 
(constant, 200 mA) using the Xcell4 SureLock Midi-Cell 
system with 1x NuPAGE MES SDS running buffer (Life 
Technologies). After rinsing the gel with MQ, we colored the 
proteins by incubating the gel for one hour in ca. 20 mL 
SimplyBlue™ Safestain (Invitrogen) while gently rocking. 
After rinsing the gel three times with MQ during 5 minutes, we 
Fig. A.1 SDS-PAGE of the
purified royalactin. Left lane:
SeeBlue Plus2 Pre-stained
Standard (with sizes in kDa).
Right lane: 9 µg of the pooled
royalactin (which was used in
the lifespan assays). 
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took a picture with a Nikon D5100. To obtain a clearer image of the protein bands, we 
digitally inverted the colors of the picture. 
This resulted in a single protein band (Fig. A.1) where one would expect royalactin (55-57 
kDa). Other major royal jelly proteins (MRJPs), that were present in the RJ-gel prior to RP-
HPLC (see A.1), show no visible bands. This further corroborates a successful extraction of 
royalactin from RJ, as already suggested by our MS data (see A.5). 
A.7 Blue native PAGE 
To assess whether our purified MRJP1 is present as a monomer or oligomer, we subjected it 
to non-reducing and non-denaturing gel electrophoresis, very similar to Tamura et al. (2009). 
We used the NativePAGE Novex Bis-Tris Gel system (Life 
Technologies) to estimate the molecular mass of native MRJP1. 
Fifteen µg of purified MRJP1 (see A.1 – A.2) was mixed with 
NativePAGE sample buffer (Life Technologies) and Coomassie 
Brilliant Blue G-250 (Sigma) according to the manufacturer’s 
instructions and brought onto a NativePAGE Novex 4-16% Bis-
Tris Protein Gel (1.0 mm, 10 wells, Life Technologies). The gel 
was subjected to 140 minutes at 150V using the XCell™ 
SureLock™ Mini-Cell system (Life Technologies). As a 
molecular weight marker we used the NativeMark Unstained 
Protein Standard (Life Technologies). After fixating the gel in a 
solution with 50% (v/v) methanol and 10% (v/v) acetic acid for 
one hour, the gel was stained with SimplyBlue Safestain (Life 
Technologies) as described previously (see A.6). Note that weight 
estimation via this electrophoretic method is not as accurate as 
with SDS-PAGE, since electrophoretic mobility also depends on 
protein shape and not exclusively on protein size. More 
information concerning the used method, also known as Blue 
native PAGE, can be found in the literature (Wittig et al. 2006). 
Our purified MRJP1 shows a strong band (Fig. A.2, between 66 
kDa and 146 kDa), corresponding to where one would expect 
monomeric MRJP1 (Tamura et al. 2009). A band around 290 kDa, which is characteristic for 
MRJP1 in the oligomeric form (Tamura et al. 2009), was not observed. In summary, this 
Fig. A.2 Native PAGE of
purified royalactin. Lane
one: fifteen µg of purified
royalactin (which was used
in the lifespan assays).
Lane two: NativeMark
Unstained Protein Standard
(with sizes in kDa).  
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result indicates that the MRJP1 obtained through our purification method is predominantly 
present in the monomeric form (which is referred to as royalactin).  
 
A.8 Verification of deglycosylation   
We performed N-linked deglycosylation of purified royalactin (MRJP1 monomer) under non-
denaturing conditions (see 2.3) and analyzed the resulting product by gel electrophoresis. 
SDS-PAGE was performed using a 
Criterion™ XT Bis-Tris gel (4–12%, 1.0 
mm, 26 wells, Bio-Rad) with XT MOPS 
running buffer (Bio-Rad) in accordance 
with the manufacturer’s instructions. As a 
molecular weight ladder we used the 
Precision Plus Protein™ Unstained 
Standard (Bio-Rad). The gel was stained 
and imaged as described earlier (A.6).  
The removal of carbohydrate moieties from 
MRJP1 has been reported in literature 
(albeit under denaturing conditions: Ohashi 
et al. 1997; Kamakura et al. 2001; 
Kamakura 2002) and results in a 
characteristic shift in apparent molecular 
weight from ~56 kDa to ~47 kDa (SDS-
PAGE). We observed an analogous shift 
(Fig. A.3: lane 2 versus lane 3), indicating 
successful deglycosylation. The 
oligosaccharide fractions obtained via 
filtering of the heat-treated and 
deglycosylation reaction mixtures (see 2.3), show no clear bands (Fig. A.3: lane 5 and lane 6). 
 
  
Fig. A.3 SDS-PAGE to verify deglycosylation.
Lane 1: 0.5 µg hRoyalactin, lane 2: 0.5 µg
dRoyalactin, lane 3: 0.5 µg royalactin, lane 4:
10 µL Precision Plus Protein Unstained Standard
(with sizes in kDa), lane 5: 0.6 µl filtrate from
hRoyalactin (equivalent to 0.5 µg protein), lane 6:
0.6 µl filtrate from dRoyalactin (equivalent to 0.5
µg protein). 
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Appendix B. 
 Additional information regarding the lifespan experiments 
 
 
Abbreviations 
FUdR   5-fluoro-2’-deoxyuridine 
IPTG   Isopropyl β-D-1-thiogalactopyranoside 
LB   Lysogeny broth 
LB Amp  Lysogeny broth containing 50 µg/mL ampicillin 
MCS   Multiple cloning site 
MLS   Mean lifespan 
 
B.1 Composition of C. elegans media 
The composition of the NGM agar differed between the lifespan experiments. This was partly 
due to application of RNAi (by feeding) in the second and third experiment, which requires 
isopropyl β-D-1-thiogalactopyranoside (IPTG) and ampicillin. 
 NGM1 agar: 1.7% (w/v) agar, 50 mM NaCl, 0.25% (w/v) Bacto™ Peptone, 10 µg/mL 
cholesterol, 2 mM MgSO4, 2 mM CaCl2, 20 mM KH2PO4, 5 mM K2HPO4. 
 NGM2 and NGM3 agar: 1.7% (w/v) agar, 50 mM NaCl, 0.50% (w/v) Bacto™ Peptone, 5 
µg/mL cholesterol, 1 mM MgSO4, 1 mM CaCl2, 20 mM KH2PO4, 5 mM K2HPO4, 1 mM 
IPTG, 50 µg/mL ampicillin. 
 NGM4 agar: identical to NGM2 and NGM3 apart from IPTG which was omitted.  
Additional protein (i.e., royalactin and BSA) was always added to the liquid NGM agar (at ± 
50°C) immediately prior to pouring the plates. The same goes for IPTG, ampicillin, CaCl2, 
MgSO4, KH2PO4, K2HPO4 and cholesterol (added as 5 mg ml-1 in ethanol). After pouring the 
NGM2 and NGM3 agar plates, they were stored for 24 hours in the dark at room temperature, 
prior to seeding with dsRNA-producing bacteria.  
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Table B.1 Different conditions used in the first C. elegans lifespan experiment. 
pRoyalactin and pBSA refer to thermolysin-treated royalactin and thermolysin-treated BSA, respectively 
(see 2.2). All plates were seeded with OP50. 
Name condition [Royalactin]  
µg mL-1 NGM1 
[BSA] 
 µg mL-1 NGM1 
[pRoyalactin]  
 µg mL-1 NGM1 
[pBSA] 
µg mL-1 NGM1 
Royalactin 0.04 µg 0.04 4.96 0 0 
Royalactin 0.4 µg 0.4 4.6 0 0 
Royalactin 1.6 µg 1.6 3.4 0 0 
BSA 0 5.0 0 0 
No protein 0 0 0 0 
pBSA 0 0 0 5.0 
pRoyalactin 0.4 µg 0 0 0.4 4.6 
pRoyalactin 1.6 µg 0 0 1.6 3.4 
 
 
Table B.2 Conditions used in the second C. elegans lifespan experiment. Plates were seeded with 
HT115(DE3) containing an empty pL4440 plasmid or pL4440(lin-3). 
Name condition [Royalactin]  
µg mL-1  
NGM2 
[BSA] 
µg mL-1  
NGM2 
Target gene 
(RNAi) 
Extra info 
pL4440 + BSA 0 5 None Negative control 
pL4440 + Royalactin 1.5 3.5 None Positive control 
RNAi lin-3 + BSA 0 5 lin-3 EGF knockdown 
RNAi lin-3 + Royalactin 1.5 3.5 lin-3 EGF knockdown 
 
 
Table B.3 Conditions used in the third C. elegans lifespan experiment. Plates were seeded with 
HT115(DE3) containing an empty pL4440 plasmid or pL4440(let-23). 
Name condition [Royalactin] 
µg mL-1  
NGM3 
[BSA] 
µg mL-1 
NGM3 
Target gene 
(RNAi) 
Extra info 
pL4440 + BSA 0 3 None Negative control 
pL4440 + Royalactin 1.6 1.4 None Positive control 
RNAi let-23 + BSA 0 3 let-23 EGFR knockdown 
RNAi let-23 + Royalactin 1.6 1.4 let-23 EGFR knockdown 
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Table B.4 Conditions used in the fourth C. elegans lifespan experiment. Note that we seeded the plates 
with the ampicillin-resistant HT115(DE3) containing an empty pL4440 plasmid, without inducing the 
production of dsRNA. We did this so we could use ampicillin to reduce potential contamination as a result 
of the processing of dRoyalactin and hRoyalactin under non-sterile conditions (i.e., 60 h at 37°C). 
dRoyalactin and hRoyalactin refer to deglycosylated and heat-treated royalactin, respectively (see 2.3). 
Name condition [Royalactin]  
µg mL-1  
NGM4 
[dRoyalactin]
µg mL-1  
NGM4 
[hRoyalactin]
µg mL-1  
NGM4 
[BSA] 
µg mL-1
NGM4 
Extra info 
Royalactin 1.6 0 0 1.4 Positive control (intact royalactin) 
dRoyalactin  0 1.6 0 1.4 Deglycosylated royalactin 
hRoyalactin 0 0 1.6 1.4 Control for heat-degradation 
Oligosaccharides  0 0 0 3 Sugar chains removed from royalactin
BSA (control) 0 0 0 3 Negative control 
 
B.2 Seeding agar plates 
 Experiment 1: We picked a single colony of E. coli OP50 into 30 mL lysogeny broth (LB, 
Sigma) medium and incubated it overnight at 37°C while shaking. Next, the liquid OP50 
culture was applied on fresh NGM1 agar plates and spread out using sterile technique. The 
surface of medium-sized plates was covered completely with 150 µL of the bacterial solution, 
while assay plates were only covered for 2/3th with 30 µL of the bacterial solution (in the 
centre of the plate, to prevent worms from crawling off during the lifespan assays). After 
overnight incubation at 37°C, and 24 hours at room temperature, the plates were stored at 4°C 
or used immediately. 
 Experiment 2, 3 and 4: Plates were seeded with an overnight culture of the E. coli strain 
HT115(DE3) (containing the appropriate RNAi construct), grown in LB medium with 50 
µg/mL ampicillin (LB Amp). We used 60 µL of bacterial culture per assay plate, and 300 µL 
per medium-sized plate. Plates were incubated at 37°C overnight, followed by 24 hours at 
room temperature in the dark before storage at 4°C. To prevent internal hatching (see B.4) we 
added 5-fluoro-2’-deoxyuridine (FUdR) with a final concentration of 100 µM to the assay 
plates, ca. 30 min before transferring worms onto them.  
B.3 Cycle sequencing of the RNAi constructs 
Every RNAi construct (i.e., pL4440 plasmid coding for a specific dsRNA) was checked by 
DNA sequencing. For this plasmid DNA from the different RNAi clones was extracted with a 
GenElute™ HP Plasmid Miniprep Kit (Sigma). DNA concentrations were measured with a 
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Nanodrop spectrophotometer (Nanodrop ND-1000, Isogen Life Science, De Meern, the 
Netherlands). We then performed a cycle sequencing reaction (Primrose and Twyman 2006) 
using a BigDye® Terminator Cycle Sequencing Kit v1.1 (Applied Biosystems, Foster City, 
USA) and a TProfessional Standard 96 well Thermocycler (Biometra, Westburg, Germany).  
Reactions were performed in a volume of 20 µL with: 1 µL of a 3.2 µM primer solution 
(pL4440-dest-RNAi-REV universal primer 5'-TGGATAACCGTATTACCGCC-3'), 2 µL 
2.5x Ready Reaction Premix, 6 µL 2.5x BigDye Sequencing Buffer and ca. 150-200 ng of 
plasmid DNA in GenElute™ HP Miniprep elution buffer (10 mM Tris-HCl, pH 8.5). After an 
initial denaturation step during 2 min at 96°C, samples were subjected to 25 cycles of 30 s at 
95°C (denaturation), 15 s at 50°C (primer hybridization) and 2 min 30 s at 60°C (elongation). 
After a final elongation step of 3 min, the extension products were precipitated via the 
Ethanol/EDTA/Sodium acetate method, as described in the manual of the BigDye® 
Terminator Cycle Sequencing kit. Actual DNA sequencing, by capillary electrophoresis and 
detection of the incorporated fluorescent dideoxynucleotides, took place on a Hitachi 3130 
Genetic Analyzer (Applied Biosystems). The obtained sequences were aligned with the 
C. elegans genome and/or the pL4440 vector sequence through BLASTn (Madden 2003). 
As expected, the “empty pL4440 construct” only contains the unmodified multiple cloning 
site (MCS) of the pL4440 vector between both T7 promoters (Output BLAST: identity 100%, 
E value 9E-111, max score 401). The pL4440(unc-22) and pL4440(lin-3) constructs also 
contain the correct insert in the MCS (Output BLAST: identity 98%, E value 8E-175, max 
score 614 and identity 99%, E value 0.0, max score 1068, respectively). 
The RNAi construct for let-23 from the Ahringer RNAi feeding library (Kamath et al. 2003) 
turned out to hold an incorrect insert. The MCS indeed contains a genomic fragment of 
C. elegans (cf. Cosmid F49E12, position 28144-28563; identity 97%, max score 699, E value 
0.0), yet it’s a sequence ca. 1 million base pairs removed from the let-23 gene. This result was 
deposited in the CelRNAi database (Qu et al. 2011) together with information from our first 
pilot experiment (see B.4). This outcome led us to build or own in-house let-23 RNAi 
construct (see B.5; Output BLAST: identity 100%, E value 0.0, max score 1142) to knock 
down let-23 in the third lifespan experiment. 
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B.4 Pilot experiments to confirm RNAi induction  
Before the second lifespan assay we performed a pilot experiment to see if RNAi was induced 
successfully at the desired experimental conditions: at 20°C, with worms on the RNAi plates 
starting from the L1 stage. When performing RNAi against unc-22 (see 2.5.4) we observed 
the expected “twitching” phenotype (Benian et al. 1993; Fire et al. 1998) – both in the 
presence and absence of royalactin – in ca. 99% of the worms after 4 days at 20°C (4 replicas; 
>300 animals). Worms fed with the empty pL4440 vector, which leads to the production of a 
dsRNA fragment corresponding to the MCS of the plasmid, showed no unusual phenotype (as 
expected).  
When feeding worms with the lin-3 RNAi clone (from the C. elegans ORF-RNAi library 
v1.1) approx. 95% of the worms died after the first day of adulthood. Presumably this was 
due to the inability to develop a vulva opening (a process in which LIN-3 plays an important 
role; Hill and Sternberg 1992) and the subsequent internal hatching of eggs (i.e., “bag of 
worms phenotype”). Adding FUdR to the plates (from the late L4 stage; 100 µM mL-1 NGM), 
which eliminates live progeny, solved this problem. 
When feeding worms with the let-23 RNAi clone from the Ahringer RNAi feeding library 
(Kamath et al. 2003) there was no difference in phenotype compared to control worms (fed 
with the RNAi clone containing the empty vector). Nor did we see a “bag of worms” or 
“vulvaless” phenotype as one would expect when successfully knocking down let-23. After 
DNA sequencing analysis, the RNAi clone turned out to be incorrect (see B.3). This led us to 
build or own in-house let-23 RNAi construct (see B.5). 
Before the final lifespan experiment we performed another pilot experiment in which we fed 
wild-type worms with HT115(DE3) containing our in-house let-23 RNAi construct 
(pL4440(let-23)). Median lifespan was reduced from 18 days to 12 days (-33.3%) compared 
to a control fed with the empty pL4440 vector (on standard NGM with 1 mM IPTG and 50 µg 
mL-1 ampicillin). Mean lifespan was reduced from 17.3±0.46 to 12.7±0.38 (-26.6%; pcox = 
3.17E-11). These results suggest a successful knockdown of let-23, with no complete loss-of-
function (cf. the latter is seen with the let-23(n1045) mutant, which has an even shorter mean 
lifespan at 20°C (Liu et al. 2011)).  
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B.5 Establishing the pL4440(let-23) RNAi construct  
We amplified a 1049 bp fragment of let-23 from genomic C. elegans DNA by PCR and 
cloned it into the pL4440 RNAi feeding vector. The method we used is comparable to the one 
described by Kamath and Ahringer (2003), with a few adjustments. 
As target sequence in let-23, we chose a region very similar to the region delineated by the 
GenePair ZK1067.1 (WormBase release WS236, Wormbase ID WBGene00002299), with a 
slight modification to the anneal site of the reverse primer. Near the 5’ end of both primers we 
incorporated a restriction site (GAGCTC) for the SacI restriction endonuclease (Thermo 
Scientific). This enzyme cuts in the MCS of the pL4440 vector (at position 75), but not in our 
let-23 target sequence. We also added a three nucleotide spacer (with sequence CTC) at the 5’ 
end of both primers, which is needed for the proper functioning of SacI.  
Forward primer = 5’-CTCGAGCTCATGCACGATGATGGTTTGAA-3’ (plus strand) 
Reverse primer = 5’-CTCGAGCTCCGGTTTGACCATCTTCATTT-3’   (minus strand) 
 
Target sequence: 
ATGCACGATGATGGTTTGAAAATTGTCACTATCTACAGACCTCTCGGAAATCTTCAAAACTTTTTGAAACTTCACAAGGAAAATTTGGGTGCACGAGAACAAGTATT
ATATTGTTATCAAATTGCATCTGGAATGCAATATTTAGAGAAACAGCGAGTTGTTCACAGAGATTTGGCAACAAGAAATGTTCTTGTGAAGAAGTTCAATCACGTGG
AAATCACTGATTTTGGTCTCTCTAAAATTCTGAAACATGACGCCGACTCAATCACTATCAAATCTGGAAAAGTTGCAATCAAATGGCTTGCGATCGAAATCTTCTCC
AAACATTGTTACACCCATGCTTCTGATGTTTGGGCATTTGGAGTCACATGTTGGGAGATTATAACATTTGGACAAAGTCCGTATCAAGGAATGTCGACTGATAGTAT
TCATAATTTCTTGAAAGATGGAAACCGTCTTTCCCAGCCACCAAACTGCTCTCAAGACTTGTATCAAGAGCTTCTGAGATGTTGGATGGCGGATCCAAAGTCTCGTC
CTGGTTTTGAAATATTATATGAAAGATTTAAAGAATTCTGTAAGGTTCCCCAACTTTTCCTGGAAAATTCCAACAAGATTTCTGAATCTGATTTGTCAGCTGAAGAA
CGTTTTCAAACGGAAAGAATCCGAGAAATGTTTGATGGAAATATCGATCCACAGATGTACTTTGATCAAGGAAGTTTACCAAGTATGCCAAGTTCTCCAACTTCTAT
GGCAACGGTAAGCATTTTTAATTAGTTTTTTTTTTCGAATATCAAATAATATTTTTACAGTTCACAATTCCACATGGTGATCTGATGAATCGAATGCAATCAGTAAA
CTCATCTAGGTACAAAACGGAGCCTTTTGATTGTAAGTTATTCTAATTTCCTTTTTTCAATTTTTATAATTATTTTGCATTTTAGATGGGTCAACCGCACAGGAAGA
TAATTCATATCTTATTCCAAAAACCAAAGAAGTTCAGCAGTCAGCAGTTTTGTATACAGCTGTTACAAATGAAGATGGTCAAACCG 
 
We amplified the above target sequence from ca. 100 ng genomic DNA using the PfuUltra II 
Fusion HS DNA Polymerase (Agilent, Santa Clara, USA), following instructions of the 
supplier. Successful amplification was checked via Tris-acetate-EDTA agarose gel 
electrophoresis and staining of the DNA with GelRed™ (Biotium, Hayward, USA). After 
purification of the PCR product (QIAquick PCR Purification Kit, Qiagen, Hilden, Germany), 
we cloned the let-23 fragment into the pL4440 vector (Addgene, Cambridge, USA, 
http://www.addgene.org/1654/) using SacI and T4 DNA Ligase (Thermo Scientific). Next we 
transformed One Shot E. coli TOP10 Competent Cells using ampicillin selection. Positive 
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transformants were screened by PCR (using a T7 primer: 5’-
TAATACGACTCACTATAGGG-3’) to verify the presence of an insert in the MCS of the 
pL4440 vector. Plasmid DNA was isolated and sequenced (as described in B.3) to confirm the 
actual identity of the insert (i.e., the desired target sequence from let-23). Finally we 
transformed E. coli HT115(DE3) competent cells, similarly to Kamath and Ahringer (2003), 
with our in-house pL4440(let-23) construct. Positive clones were sequenced once more as 
described in B.3, with the difference that we now used the M13 Forward (-21) primer (from 
the BigDye® Terminator Cycle Sequencing Kit v1.1) to verify the presence of the correct 
insert. 
 
B.6 Additional lifespan curves and p-values 
B.6.1 EGF knockdown 
  
     
 
 
 
 
 
 
 
 
 
Fig. B.1. The lifespan-extending effect of royalactin is maintained when culturing C. elegans 
in the presence of HT115(DE3) expressing dsRNA corresponding to the MCS of the pL4440 
vector during the second lifespan experiment. Worms treated with 1.5 µg royalactin mL-1 
NGM2 live significantly longer than those treated with only BSA (plog-rank = 0.00254; pcox = 
0.00343). 
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Fig. B.2. When knocking down lin-3, which codes for the EGF ligand LIN-3, royalactin-
treatment does not result in a significant increase in survival (plog-rank = 0.372; -1.9% MLS). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. B.3. Knockdown of lin-3 causes no significant difference in survival (compared to the 
control with the empty pL4440 vector) on NGM2 agar plates supplemented with BSA (plog-rank 
= 0.256; -4.8% MLS). 
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Fig. B.4. On agar plates with 1.5 µg royalactin mL-1 NGM2, MLS decreased by 20.5% when 
knocking down lin-3 compared to the control fed the empty vector (plog-rank = 1.26E-8).  
 
B.6.2. EGFR knockdown 
 
 
 
 
 
 
 
 
 
Fig. B.5.  Knockdown of let-23 drastically decreases survival of C. elegans on NGM3 agar 
plates supplemented with BSA (pcox = 1.47E-8; plog-rank = 7.29E-09; -26.8% MLS). 
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Fig. B.6. The lifespan-extending effect of royalactin is maintained when culturing C. elegans 
in the presence of HT115(DE3) expressing dsRNA corresponding to the MCS of the pL4440 
vector during the third lifespan experiment. Worms treated with 1.6 µg royalactin mL-1 NGM3 
live significantly longer than those treated with only BSA (pcox = 5.69E-4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. B.7. When knocking down let-23 the lifespan-extending effect of royalactin is 
completely abolished. There is even a slight, albeit non-significant, reduction in MLS of 8.2% 
(plog-rank = 0.062).  
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